Skip to content

Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars

Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06943118
Enrollment
60
Registered
2025-04-24
Start date
2025-04-30
Completion date
2025-10-31
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Acne Scars

Brief summary

The goal of this clinical trial is to compare the effectiveness of two drugs in patients that presents with scars on face after acnes. The effectiveness will be measured by a goodman and baron scale. One group of patients will receive 35% glycolic acid while other group of patients will receive 20% salicylic acid and both groups will be followed by 12 weeks.

Interventions

Chemical peel is a dermatological procedure in which chemical solution is applied to the skin to remove the top layer

Sponsors

Hayatabad Medical Complex
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-45 years with mild to moderate atrophic post acne scars * Fitzpatrick skin type 2-4 * No active acne or ongoing systemic acne treatment

Exclusion criteria

* Pregnancy and breast feeding * History of keloid or hypertrophic scars * Use of retinoids or chemical peel in last 3 months * Active skin infections * History of hyperpigmentation after any procedure * Hypersensitivity to aspirin

Design outcomes

Primary

MeasureTime frame
improvement in acne scars as per Goodman and baron scale6 months

Countries

Pakistan

Contacts

Primary ContactKhizar Hayat, MBBS
ayubian944@gmail.com+923159446988
Backup ContactNaheed Asghar, MBBS,FCPS
03164040189

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026